Opening book details…
About this Medicine article
1028PMirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin and bevacizumab: Initial results from a phase Ib study in patients (pts) with ovarian cancer by O'Malley, D; Richardson, D; Vergote, I B; Gilbert, L; Martin, L P; Mantia-Smaldone, G M; Castro, C; Provencher, D; Matulonis, U A; Malek, K; Moore, K N is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- O'Malley, D; Richardson, D; Vergote, I B; Gilbert, L; Martin, L P; Mantia-Smaldone, G M; Castro, C; Provencher, D; Matulonis, U A; Malek, K; Moore, K N
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2019
- Field
- Medicine (Health Sciences)